• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION SMART CONTROL NITINOL STENT SYSTEM; SELF EXPANDING STENTS (NIO)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION SMART CONTROL NITINOL STENT SYSTEM; SELF EXPANDING STENTS (NIO) Back to Search Results
Catalog Number C08080SL
Device Problem Torn Material (3024)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/24/2015
Event Type  malfunction  
Event Description
As reported, during a percutaneous transluminal angioplasty (pta) the smart control 8 x 80 stent delivery system was attempted to be delivered to the intended target lesion.It was noted that the distal tip of the catheter was frayed.Therefore, the physician stopped using it, and new smart control was used instead.The procedure was finished successfully.There was no reported patient injury.The product was clinically used and it will not be returned for analysis.The target lesion was the superficial femoral artery (sfa).The lesion was reported to be: mildly calcified and not tortuous.The lesion was crossed with an unknown guidewire.Additional information has been requested.
 
Manufacturer Narrative
(b)(6).The product is not available for evaluation and testing.Additional information will be submitted within 30 days upon receipt.
 
Manufacturer Narrative
Complaint conclusion: during an angioplasty, the physician had difficulty tracking a smart control 8 x 80mm stent delivery system (sds) to the target lesion and noted that the distal tip of the sds was frayed.The device was exchanged and the procedure successfully completed with no reported patient injury.The event involved a patient undergoing angioplasty of a mildly calcified, non-tortuous lesion in the superficial femoral artery.The lesion was successfully crossed with an unknown guidewire.The site reported that the sds packaging was inspected prior to use and no damages were noted.No difficulty was experienced when removing the device from the packaging and the device was noted to be un-damaged.The product was prepped according to the instructions for use (ifu) with no problems experienced.The smart control sds was loaded on the guidewire but difficulty was experienced in tracking the device to the target lesion.The physician noted that the distal tip of the sds was frayed.It is unclear from the report whether this damage was noted after product removal or not.The procedure was completed with a similar device with no reported patient injury.The product was not returned for evaluation.A review of the manufacturing records revealed that this lot of products met specification prior to release.The product ifu details that if resistance is met during delivery system introduction, the system should be withdrawn and another system should be used.Pushing the sds against resistance, which can be encountered during sds advancement through calcified, tortuous or stenotic vasculature, can cause the outer member to compress.Based on the limited information available for review, it is not possible to determine what factors may have contributed to the reported issue.Without the return of the device for analysis, the reported customer complaint could not be confirmed and no determination of possible contributing factors could be made.Based on the device history record review, there is no indication that the event is related to the device manufacturing process.Therefore, no corrective actions will be taken at this time.
 
Manufacturer Narrative
Additional information received indicated that the complaint product was not able to reach the intended target lesion.There was no damage noted to the product packaging upon inspection prior to opening.There was no reported difficulty removing the product from the packaging.The product was inspected prior to use and appeared to be normal.The product was prepped properly according to the instructions for use (ifu) with no problems noted.No additional information is available.Additional information will be submitted within 30 days upon receipt.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMART CONTROL NITINOL STENT SYSTEM
Type of Device
SELF EXPANDING STENTS (NIO)
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th avenue
miami lakes FL
Manufacturer Contact
cecil navajas
circuito interior norte #1820
juarez chihuahua 32580
MX   32580
7863133880
MDR Report Key4613982
MDR Text Key5587644
Report Number9616099-2015-00125
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P020036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 04/21/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2016
Device Catalogue NumberC08080SL
Device Lot Number17099279
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/21/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/25/2014
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-